Trial Profile
A Phase 2 trial CYP-001 critical limb ischemia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2018
Price :
$35
*
At a glance
- Drugs CYP 001 (Primary)
- Indications Chronic limb-threatening ischemia
- Focus Therapeutic Use
- 15 Nov 2018 New trial record